Jamie Wilkinson new Healthcare Biotechnology Director at EuropaBio
PRESS RELEASE
Brussels, 23 May 2022 – EuropaBio is delighted to announce that Jamie Wilkinson has been appointed as the new Healthcare Biotechnology Director at EuropaBio.
Jamie is a pharmacist with an extensive experience in European and global health and pharmaceutical policies. He has experience navigating the health policy ecosystem in Brussels and beyond - gained from policy roles in non-governmental organisations, professional and patient-led organisations, trade associations, and pharmaceutical and biotechnology companies. He holds a Professional Diploma in Public Relations, master’s degrees in pharmacy, health policy, and public health, as well as professional registrations in public health, regulatory policy, public relations, and pharmacy.
Speaking about his appointment, Jamie said: "I am excited to join EuropaBio at a pivotal time of European pharmaceutical policy revision, and to contribute to the healthcare policy transformation that will boost innovation, create the right environment to attract investments, and deliver biotechnology excellence in Europe."
Claire Skentelbery, Director General of EuropaBio commented: "We are delighted to welcome Jamie to the team as Healthcare Biotechnology Director. He will work across members to implement their policy priorities and drive ambitious advocacy strategies for a healthcare regulatory framework in Europe that delivers its full promise to patients, economic development and next generation technologies."
Jamie will take on the new role with immediate effect.
Jamie is a pharmacist with an extensive experience in European and global health and pharmaceutical policies. He has experience navigating the health policy ecosystem in Brussels and beyond - gained from policy roles in non-governmental organisations, professional and patient-led organisations, trade associations, and pharmaceutical and biotechnology companies. He holds a Professional Diploma in Public Relations, master’s degrees in pharmacy, health policy, and public health, as well as professional registrations in public health, regulatory policy, public relations, and pharmacy.
Speaking about his appointment, Jamie said: "I am excited to join EuropaBio at a pivotal time of European pharmaceutical policy revision, and to contribute to the healthcare policy transformation that will boost innovation, create the right environment to attract investments, and deliver biotechnology excellence in Europe."
Claire Skentelbery, Director General of EuropaBio commented: "We are delighted to welcome Jamie to the team as Healthcare Biotechnology Director. He will work across members to implement their policy priorities and drive ambitious advocacy strategies for a healthcare regulatory framework in Europe that delivers its full promise to patients, economic development and next generation technologies."
Jamie will take on the new role with immediate effect.
